Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03278379
Title Avelumab in G2-3 NET (NET-002)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications

gastrointestinal neuroendocrine tumor

pulmonary neuroendocrine tumor

Therapies

Avelumab

Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Sunnybrook Health Sciences Centre Toronto Ontario M4N3M5 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field